Talphera (TLPH) Operating Expenses (2010 - 2026)
Talphera's (TLPH) quarterly Operating Expenses came in at $3.9 million in Q1 2026, up 34.15% year-on-year from $2.9 million in Q1 2025, and up 14.34% quarter-over-quarter from $3.5 million in Q4 2025.
Talphera (TLPH) Operating Expenses (2010 - 2026) Analysis & Trends
Talphera's Operating Expenses history runs 17 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Operating Expenses rose 34.15% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $14.5 million, a 4.0% increase from a year earlier, with the FY2025 full-year figure at $13.5 million, down 11.41% from the prior year.
- Operating Expenses advanced to $3.9 million in Q1 2026 per TLPH's latest filing, from $3.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $10.0 million in Q2 2022 and bottomed at $2.9 million in Q1 2025.
- The 5-year median for Operating Expenses is $4.1 million (2023), against an average of $4.7 million.
- Across the five-year window, Operating Expenses slumped 57.59% in 2023 and soared 34.15% in 2026, its largest moves.
- Year by year, Operating Expenses stood at $5.9 million in 2022, then fell by 22.46% to $4.6 million in 2023, then tumbled by 34.36% to $3.0 million in 2024, then rose by 15.25% to $3.5 million in 2025, then rose by 14.34% to $3.9 million in 2026.
- Per Business Quant, the three latest TLPH Operating Expenses figures stand at $3.9 million (Q1 2026), $3.5 million (Q4 2025), and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 3.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.95 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.69 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 4.56 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 9.44 Mn |
| Dec 31, 2021 | 8.18 Mn |
| Sep 30, 2021 | 10.50 Mn |
| Jun 30, 2021 | 10.46 Mn |
| Mar 31, 2021 | 9.65 Mn |